IRMD
IRMD
NASDAQ · Health Care

Iradimed Corp

$99.50
-0.35 (-0.35%)
As of Mar 22, 10:10 PM ET ·
Financial Highlights (FY 2026)
Revenue
77.60M
Net Income
20.81M
Gross Margin
76.7%
Profit Margin
26.8%
Rev Growth
+16.3%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.7% 76.7% 64.3% 64.3%
Operating Margin 31.2% 28.1% 20.9% 21.7%
Profit Margin 26.8% 25.5% 19.7% 18.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 77.60M 66.73M 371.28M 367.15M
Gross Profit 59.56M 51.21M 238.61M 235.95M
Operating Income 24.21M 18.74M 77.66M 79.60M
Net Income 20.81M 16.11M 73.06M 68.53M
Gross Margin 76.7% 76.7% 64.3% 64.3%
Operating Margin 31.2% 28.1% 20.9% 21.7%
Profit Margin 26.8% 25.5% 19.7% 18.7%
Rev Growth +16.3% +16.3% +3.1% +13.0%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 192.97M 209.74M
Total Equity 936.02M 858.01M
D/E Ratio 0.21 0.24
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 26.26M 21.45M 107.10M 104.64M
Free Cash Flow 59.94M 58.81M